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Abstract:
The many roles mass spectrometry plays in the discovery and development of
chemical entities by both the biotechnology and pharmaceutical industries are
highlighted. Innovations in sample preparation for mass spectrometry have allowed
accelerated the throughput of combinatorial chemistry and pharmacokinetic studies.
Quantitative analysis of Liquid Chromatography coupled to a Tandem Mass
Spectrometer (LC/MS/MS) has been used in this experiment for _a dynamic range of
10 ng/mL to 2500 ng/mL in rat plasma of many analytes. The calibration curve in
this experiment was generated using an automated method (packard Multiprobe II)
and compared to a manual method (prepared by an analyst). A student t test was used
to determine if the automated vs. manual methods gave significantly different results.
A three day validation of compound A in rat plasma has been used to
determine reproducibility, accuracy, and ruggedness of the assay using the Packard
Multiprobe II robotic system. The samples were quantified utilizing Liquid
Chromatography coupled to a Mass Spectrometer (LC/MS). The results from the
validation were acceptable since the average within-run precision and average bias
for all levels of quality control samples were less than 15 percent. The between-run
precision and average bias for all validation runs were also less than 15 percent.
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Introduction
High throughput screening and the application of combinatorial chemistry to
compound discovery have changed the traditional serial process of lead optimization
and identification that preceded investigations of the development of drugs.
Recently, an incredible amount of new chemical entities have been synthesized in
parallel using combinatorial chemistry. The compounds have been tested rapidly
using high throughput screening, therefore, the synthesis of new discovery
compounds is no longer the time limiting step. The new bottleneck is currently
sample preparation of the thousands of pharmacokinetic, intrinsic clearance, protein
binding, and other types of study test articles generated by the discovery or
development groups in the pharmaceutical industry.
In order to cope with this new research and development trend in the
pharmaceutical industry, several analytical instruments have been developed. The
mass spectrometer is now one of the most critical tools for the entire drug discovery
process using combinatorial chemistry and high throughput screening.
There has been a need to develop more automation techniques in conjunction
with 96 well plates to be able to serve the demand of customers in the pharmaceutical
industry. Statistical information and validations must be generated to assure that the
newer techniques utilized are dependable.
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History of LCIMS
Mass Spectrometry (MS) has been around for more than 80 years, but it has
not impacted the drug discovery industry until recently. When mass spectrometry
was introduced, it was narrowly focused on a set of gas-phase analytical techniques.
A single sample was entered into the mass spectrometer via a vacuo lock and ionized
in vacuo by bombardment with energized particles, usually electrons (electron
bombardment ionization), neutral molecules (fast atom bombardment), or even
through the transfer of energy (electric field ionization, laser desorption, or spark
discharge). 1-2. The ionization in the gas phase was extremely difficult since mass
spectrometry caused extremely high fragmentation of the analyte ion. The matrix
would also cause an immense amount of interference with the analyte. Many
scientists working with mass spectrometry encountered problems with selectivity,
therefore, tandem MS was developed. A dramatic increase in the specificity came
forth when Liquid Chromatography (LC) columns were added to separate samples
into individual components before introduction into .the mass spectrometer.
Analytical columns were developed and used to separate compounds and endogenous
peaks.
Only about 20% of all analytes of interest were analyzed ~y GC/MS. 1 The
non-ionic compounds appeared to perform much better than ionic compounds, which
kept GC/MS very limited for the pharmaceutical industry. Unfortunately, most ofthe
drugs and metabolites are polar and ionic in nature.
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One major difficulty was matching the condensed-phase system of the
separating LC with the ultra high vacuum domain of the mass spectrometer. The
three problems that essentially had to be solved were the volatility of the solvent
(used in the LC), the flow rate of the mobile phase and the high polarity of the
compounds. The issues that were the most significant in LC/MS were analyte
stability, ionizability, and volatility.
A more "primitive" approach that scientists used for LC/MS a moving belt
interface to continually deposit drops of mobile phase effluent from the LC
experiment onto a tiny conveyer belt. 1 After the liquid vaporized, the residue was
transferred to the ion source and electron impact was utilized. Electron impact
appears to have an extremely poor response time, a decrease in resolution, and high
carryover. Other types of interfaces tried included a pneumatic nebulizer, continuous
flow fast atom bombardment, and particle beam ionization. The interfaces did have
an increase in performance, but fast atom bombardment was not able to handle
reasonable flow rates. Unfortunately, particle ionization was performed at high
temperatures, which caused thermal instability of the compounds. Scientists learned
a new lesson whenever new techniques failed.
One of the most significant improvements was discovered when the solvent
was eliminated and the nonvolatile analytes were ionized at atmospheric pressure.
From this liquid-based ionization strategy, Atmospheric Pressure Ionization (API)
mass spectrometry was born.
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One. could now use either thermospray (very soft ionization and strong
heating) or electrospray (soft ionization, high voltage, mild heating).1 These two
techniques were complementary in applicability and performance. For compounds
that were less polar APCI (Atmospheric Pressure Chemical Ionization) could be used.
A corona discharge needle was required for APCI source change. The needle assists
in the transfer of a charge to the solvent and could be used at an increased flow rate
such as 1 mL/min.
Virtually everything on the modem LC/MS is controlled by computer. After
connecting the LC with the mass spectrometer, scientists could now enJoy
tremendous selectivity, sensitivity, obtain both qualitative and quantitative data, all
applicable to many small molecules of pharmaceutical interest.
With the extreme selectivity and the separation power of the LC, now mass
spectrometrists could now analyze a single sample containing up to twenty analytes.
,Molecular weights of compounds could be determined by infusing a solvent
containing the analytes.
A mass spectrometer is capable of the following tasks: separation, formation,
rearrangement ofmolecular ions and detection of molecular ions based on the mass to
charge ratio (m/z). The compartments that make up a mass spectrometer are a sample
inlet, an ionization source, a mass analyzer, a detector, and a data processor.
The ion is either positively or negatively charged depending on the functional
groups of the molecule and the ionization mode. For example, positively charged
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molecules generally had amides and amines in their structures.! Negatively charged
ions frequently have carboxylic acid groups and/or hydroxyl functional groups.! A
molecule may be singly or multiply charged depending on its structure. If a
compound has a molecular weight of 522 and it only has one positive charged, then
the molecular ion [M+Ht will be 523. Conversely, if this p",rticular molecule had a
single negative charge the molecular ion [M-Hr on the mass spectrum would be 521.
A double positive charge on the same molecule would have a molecular ion of (m/z)
molecule + W + H+ / 2 = 262. There would be two protons added to the molecule,
and the m/z ratio is cut in half by the two charges.
The resolution of the mass spectrometer is defined qualitatively as its ability
to discriminate between adjacent ions in a spectrum.! The resolution is defined as the
function of molecular weight and is given by the following equation:
Resolution = m / .fun
where m = the molecular weight
.fun = peak width of the ion at half-height, at a given
percentage valley between the adjacent ions.
Resolution is increased when the peak width decreases for a given m, or as m is larger
without a concurrent increase in peak width.
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Combinatorial chemistry and mass spectrometry
During the past several years, combinatorial chemistry has been a key
technology for accelerating the discovery of novel therapeutic agents in the
agrochemical, biotechnology, and the pharmaceutical industries.3 Combinatorial
chemistry was first introduced by the seminal work of Merrifield4, involving solid-
phase synthes!s protocols were utilized to create small mixtures of peptides on solid
supports. This early work was the foundation of peptide libraries and combinatorial
chemistry. Combinatorial chemistry has essentially become an integral component of
nearly all drug discovery efforts.5-8
Mass spectrometry is one of the most useful instruments in the advancement
of combinatorial chemistry through the optimization of library synthesis and reaction
monitoring, assessment of library compound quality, and in the bioaffinity and
screening pharmaceutical properties of the above. The major benefits of using mass
spectrometry are the high sensitivity, specificity ofdetection, and short analysis time.9
One of the simplest ways of sample introduction to a mass spectrometer is
called Flow Injection Analysis (FIA). Minimizing carryover using FIA/MS of
combinatorial compounds was accomplished by Richmond and Goerlach. 10-12 The
samples were sorted by maximizing the molecular weight of each adjacent sample
injected. Carryover was determined to be approximately 0.01 % and the cycle time
was less than one minute per sample.
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High throughput characterization of combinatorial libraries using
parallel systems
Parallel injection may further increase FIAJMS throughput. Parallel injection
consists of a four or eight channel sprayer head (multiplexed electrospray inlet) that
directs the spray directly into an orthogonal acceleration Time of Flight (TOF) MS
or triple quadrupole MS. The sprayer streams are introduced into the MS
simultaneously, however, these streams must be sampled one at a time to minimize
cross contamination between the channels. The diagram for the four channel sprayer
head is in Figure 1.
ParalleiColumn
HPLCSyslem
~fulliple Needle
Electrospray Inlerface
Mass spectrometer
Detectton
ColumnA
ColumnB
ColumnC
ColumnD
Figure 1. Parallel LC/MS with four HPLC columns interfaced simultaneously to one mass
spectrophotometer, which provides an increase in throughput of LC/MS. This example demonstrates
eluent from each HPLC column electrosprayed into a single ion source, but only one HPLC stream is
sampled at a time by means of a rotating plate shown aligned with column "B", thus the other sprays
are blocked by the plate at this particular instant. (Based on Reference Shin et al. [13],2001.)
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Each stream of liquid was sampled for 0.1 seconds and individual mass
spectra for each analytical column were acquired in four separate data files that were
synchronized with the spray being sampled. 14 Four and eight channel sources with
the same orthogonal acceleration TOF instrument were developed; cycle times were
0.6 s and 1.2 s, respectively.15 Using an eight channel source with a 5 minute HPLC
High Performance Liquid Chromatography (HPLC) gradient elution, a 96-well
microtiter plate could be analyzed in 60 minutes.
Turbulent Flow Chromatography - Mass Spectrometry (TFC-MS)
Rapid LC/MS cycle times remain important for MS analysis of large'sample
libraries. 16 One of the most useful, rapid, and more widely used on-line LC/MS
techniques is Turbulent Flow Chromatography (TFC).
In TFC as many as four separate systems are coupled to a single MS. Each
unit is composed of two separate LCs, one of which elutes solvent to the turbulent
column and the other pump elutes solvent to the analytical column. The turbulent
pump initially uses a high flow rate (5 mL of aqueous buffer), which flows through a
turbulent column packed with a narrow internal diameter and large size particles
(50llm). The pressures are more manageable (700-1200 psi) for direct-injection
techniques with such large particles. 16 A size exclusion type of separation mechanism
is observed with turbulent flow. Macromolecules do not rapidly diffuse into the
particles pores and elute without retention, whereas small particles do diffuse and are
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retained on the column. Virtually all of the polar endogenous particles are washed off
the turbulent column by a rapid clean-up step. The compounds of interest are not
affected by the rapid rinsing and remain on the column. An organic solvent such as
acetonitrile is used to elute the compounds from the turbulent column to the analytical.
column. Both the organic and aqueous solvents will contain a low concentration of
acid to assist in the ionization of the compounds. The compounds are retained on the
analytical column during a gradient program change from 50/50 organic/aqueous
phase to 100% organic phase to separate and elute the compounds into the MS. As
the mass spectra are obtained from the first sample, the next unit is injected onto the
turbulent column. Each of the four units is sampled in turn for a 1.5 minute MS
acquisition time, yielding a total of slightly over six minutes for each cycle. Figure 2
shows the set up ofthe TFC-MS.
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Figure 2.. A schematic presentation of turbulent flow on-line extraction LCIMSIMS. Pump A
represents the aqueous mobile phase and Pump B represents the organic solvent. (Based on Reference
lemal, [16],2000.)
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The application details and principles of turbulent flow on-line extractions are found
in a number ofarticles. 17-18
Capillary Liquid Chromatography
As more potent drugs are discovered in the biotech and pharmaceutical
industry, the need to achieve better sensitivity will be a focal point. Increasing
sensitivity would also require less volume of blood or other matrices from rodent
animals or pediatric patients in order to allow several serial bleeds on each animal.
After the LC conditions, MS parameters, and chromatographic peak efficiency have
been optimized for a given assay there is little one could improve. One possibility to
increase sensitivity involves capillary LC columns for bioanalytical LC/MS/MS
methods. 19-21 A lOa-fold increase in the analyte peak concentration at the detector
can theoretically be achieved by simply reducing the diameter of the LC column from
2mm (commonly used for LC/MS), to a capillary column dimension of O.2mm.
Unfortunately, high backpressures are observed with capillary columns due to the
small internal diameter of the columns. The amount of sample that may be injected
is limited with a capillary column. It remains to be seen if rugged high throughput
capillary LC/MS/MS bioanalytical methods with short run times can be generated and
routinely used.
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Robotics for sample preparation
Another method for increasing analysis and screenmg throughput of
combinatorial libraries is the use of automated liquid handling systems. Currently,
the most frequently used robotic modules for 96-well vials are the Packard
Multiprobe (Packard Instruments, Meriden, CT, USA), Tecan (Durham, NC, USA),
and Tomtec Quadra (Tomtec, Hamden, CT, USA).22 The Tomtec has been
successfully validated by measuring concentrations of compounds in plasma23,
The Packard Multiprobe liquid handling system has many strengths for offline
Solid Phase Extraction (SPE) methods involving plasma26 and serum27• This unit and
the Tecan can be programmed to initially aliquot samples from the vials to the 96-
well blocks, then buffer and an internal standard. The amount of time and labor is
significantly reduced. Either the replacement of disposable pipet tips or several
,
washing steps need to be inserted into the sequence to alleviate carryover. Caution
must also be taken to assure that endogenous protein clots do not clog the probes.
This may cause inaccurate transfer from the reservoirs to the 96-well blocks.
The most common types of extraction techniques are: Liquid-Liquid
Extractions (LLE), Solid-Phase Extraction (SPE), and Protein Precipitation (PPT).
All robotics systems have been successfully used for these types of extractions.
Based on a series of experiments, King and colleagues has determined the order of
ESI response suppression is PPT>SPE>LLE, with the least amount of analyte ion loss
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for LLE.28 Before 1999, LLE was not very prevalent in the pharmaceutical industry.
There has been a dramatic increase in the number of articles published in this
methodology since then,z9-31 An automated sample preparation method based on a 96
well plate platform has been developed for high throughput analysis using
LC/MS/MS. A three day validation of accuracy and ruggedness was also evaluated.
The usefulness of this method is discussed in some detail.
Experimental Methods
Chemicals
Compounds A, B, and the internal standard were GlaxoSmithKline Pharmaceuticals
discovery compounds. Their actual identity is not important for testing the validity of
the tested methods.
Acetonitrile (ACN) - HPLC grade
Ammonium formate
Formic acid - reagent grade
Water, HPLC grade, Milli-Q system
Rat Plasma - heparinized
10 mM ammonium formate, pH 3.0 preparation
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EMD Chemicals Inc.
(Gibbstown, NJ)
Fisher Scientific
(Fair Lawn, NJ)
Sigma Chemical Co.
(St. Louis, MO)
Millipore Co.
(Bedford, MA)
Biological Specialties
(Colmar, PA)
To prepare this buffer, 0.63 g. of ammonium formate, was dissolved in 1.00 L
of Millipore water and adjusted to pH 3.0 with formic acid. The buffer was then
filtered through a 0.2 Ilm filter before use.
Equipment
HPLC
A quaternary solvent pumping system including two 1100 HPLC pumps from
Agilent Technologies (Palo Alto, CA) was used to deliver mobile phase to a 50mm X
3mm C18, 51lm particle size HPLC column from Phenomenex Inc. (Torrance, CA)
preceded by a 0.5 Ilm pre-column filter. All injections were made by a CTC
Analytics Pal autosampler (Zwingen, Switzerland).
MSIMS
An API-4000 triple quadrupole mass spectrometer from MDS Sciex
Instruments (Concord, Ontario, Canada) was coupled to the HPLC via a Turbo
IonSpray interface. Data acquisition, display, and automatic data processing were
performed using the Analyst™ software version 1.2, supplied by MDS Sciex
Instruments.
Automated Liquid Handling System
A Multiprobe II HT EX automated liquid handling system from Packard
(Wellesley, MA) was used for sample and standard preparation. The multiprobe did
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not use any disposable pipet tips but instead used fixed tips with a· flush wash
between liquid transfer. The multiprobe II used eight probes or arms to dispense and
aspirate reagents. The cycle time for the automated method was approximately
eleven minutes to prepare the standard curve or quality control samples. Appropriate
methods were prepared separately for the standard curve and the quality control
samples. All probes were sufficiently rinsed with Milli-Q water after each aspiration
and delivery of reagents.
Other equipment and materials
Eppendorf micro-centrifuge, model 5413 Brinkmann Instruments, Inc.
(Westbury, NY)
Eppendorf 1.5mL polypropylene tubes Brinkmann Instruments, Inc.
(Westbury, NY)
96 well plates and deep tubes MTX Labs Inc.
(Vienna, Virginia)
MultiTube vortexer Baxter Scientific Products
(McGraw Park, IL)
Eppendorf pipettes Brinkmann Instruments Inc.
(Westbury, NY)
LC and MS conditions used
Liquid Chromatography Conditions
LC used:
Mobile Phase Composition:
Flow Rate:
Column used:
Injection volume:
Acquisition time:
Agilent quaternary 1100 HPLC pump (isocratic)
72/28 acetonitrile/l0mM ammonium formate, pH 3.0
450 ilL! minute (no split)
Phenomenex C18, 51lm particle size,
50 X 3mm (length X internal diameter)
10 ilL
0.9 minute
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MS Parameters
Mass Spectrometer used: MDS, Sciex API-4000 Turbo Ionspray
Scan Type: MRM (Multiple Reaction Monitoring)
Resolution for Q1 and Q3: Unit Mass
Pause Time: 5.0 ms
Polarity Mode: negative
Temperature: 450°C
Ion Spray Voltage: - 4200
All compounds (Dwell time): 100 ms
Compound
A
B
Internal Std.
Precursor Ion (m/z)
415
459
328
Product Ions (m/z)
242
398
267
DP
-46
-82
-70
CE
-16
-28
-30
CXP
-13
-11
-15
DP: Declustering Potential CE: Collision Energy CXP: Collision Exit Potential
Compounds A, B, and the internal standard all had a single negative charge
and had molecular weights of416,460, and 329, respectively.
Results and Discussion
One of the most important steps for bioanalysis is standard and sample
preparation. Utilization of automated liquid handling systems should increase
efficiency, minimize error, and free analyst time. Two assays were performed in this
experiment. The first assay was used to compare automated vs. manual sample
preparation to make sure that the results were indistinguishable within the 95%
confidence level. The second experiment was a three day validation on the Packard
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Multiprobe II liquid handling system which included standards and quality control
samples. Utilization of automated liquid handling systems should increase efficiency,
minimize error, and is less time consuming compared to manual sample preparation.
Development of LC/MS/MS Analysis
To determine the MRM (Multi reaction monitoring) transitions, a Ql full scan
was performed to determine the precursor ions. After the precursor ions were
determined, the declustering potentials were optimized for each analyte. A separate
product ion scan of each precursor ion was used to select the product ions. The
collision energy and collision exit potential were optimized for each analyte. The Q1
full scan and product ion scan for compound A are shown in Figures 3 and 4,
respectively. The Ql full scan and product ion scans for compound B are shown in
Figures 5 and 6, respectively. The Ql full scan and product ion scan for the internal
standard are shown in Figures 7 and 8, respectively. All compounds were infused
separately in 80/20 acetonitrile /10 mM ammonium formate (pH 3.0) at a flow rate of
450 j..LL/min.
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• ·Ql: 0.031 min from MT20030410114022.wnf Max. 1.5e7 cps.
1.5e7
1.4e7
1.3e7
1.2e7
1.1e7
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9.0e6
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7.0e6
6.0e6
5.0e6
4.0e6
3.0e6
Compound A (precursor ion) --------t.~ ...
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...
2.0e6
1.0e6
240 260 280 300 320 340 360 380
m/zl amu
420 460 500
Figure 3. The Q1 full scan of Compound A at 100 ng/mL.
• ·Product(415.4): 0.142 min from MT20030410114351.wiff Max. 3.6,6 cps.
3.6,6
3.4 ,6
3.2,6
3.0,6
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m/z,amu
Figure 4. Product ion scan of Compound A at collision energy of -16eV.
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• -01: 0.031 min from MT20030408111146.wiff M3x. 8.8e5 cps.
8.5e5
8.0e5
7.5e5
7.0e5
6.5e5
6.0e5
5.5e5
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1.0e5 N e"
5.0e4 ~ I ~ I~ I0.0
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mlz, amu
Figure 5. The Q1 full scan of Compound B at 100 ng/mL.
• ·Product (459.5): 0.046 min from MT20030408113151.wiff Max. 2.505 cps.
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Figure 6. The product ion scan of Compound B at a collision energy of-26 eV.
20
• -01: 0.036 min from MT20030408121551.wiff
1.6e6
1.5e6
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Figure 7. The Q1 full scan of the internal standard at 50 ng/mL.
• -Product (328.3): 0.051 min from MT20030408122119.wiff Max. 5.7e5 cps.
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Figure 8. The product ion scan of the internal standard at collision energy of -22eV.
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Automation vs. Manual Sample Preparation
The comparison of the two standard curves consisted of preparing two
calibration curves from 10 ng/mL to 2500 ng/rnL in heparinized rat plasma on the
same day separately by both manual and automated methods. The samples were
quantitated by using an Agilent quaternary 1100 HPLC pump coupled to a Scie?, API-
4000 MS/MS. Electrospray LC/MS/MS was chosen for this experiment because of
"
the polar nature of the compounds, the high degree of selectivity, sensitivity, and
rapid analysis. A photograph of the Packard Multiprobe II are in Illustration #1. A
magnified picture of the probes, 96 well plate positions, and wash stations are shown
in Illustration #2.
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Illustration 1. A photograph of the Packard Multiprobe II Liquid Handling System
consisting ofeight samples aspirating and dispensing arms.
23
I INTENTIONAL SECOND EXPOSURE
Illustration 1. A photograph of the Packard Multiprobe II Liquid Handling System
consisting of eight samples aspirating and dispensing arms.
,~
--'
Illustration 2. A magnified picture of the Multiprobe II showing the 96 well tube
racks (bottom left), eight probes (center), and the solvent reservoirs (right side).
24
INTENTIONAL SECOND EXPOSURE
Illustration 2. A magniIied picture or the ?vlultiprobe II showing the 96 well tube
racks (bollom left). eight probes (center). and the sohent resenoirs (right side) .
. I
Each 96 well plate, solvent reservoir, and wash station has a designated
position on the multiprobe layout (i.e. ElO). The- designated position for each
accessory must match the program method, otherwise the probes will be directed to
the wrong positions. The multiprobe is capable of preparing standards and quality
control samples using two separate methods.
Table 1 illustrates how the automated and manual calibration curves were
prepared in rat plasma. Both calibration curves were prepared in 96 well tubes. Both
the manual and automated standard curves were prepared within an hour of each
other.
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ug/mL
100
20
2
0.2
Solution used
1 mg/mL
100
20
2
compounds
Aand B
stock volumes
40 of each
80
40
40
diluent volumes
320
320
360
360
standard curve
volumes of rat
plasma
292.5
285
292.5
592.5
285
292.5
592.5
285
volumes of
cone. (ng/mL) Std. Used solution
2500 100 7.5
1000 20 15
500 20 7.5
250 20 7.5
100 2 15
50 2 7.5
25 2 7.5
10 0.2 15
Table 1. Manual and Automated Standard curve preparation for Compounds A and B.
Note: 50/50 acetonitrile/water was used as the diluent. All volumes are in ilL.
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After the preparation of the standard curves, 50 uL of each standard' was
aliquoted in duplicate into separate tubes and 100 uL of internal standard (IS) in
acetonitrile was added and the solution mixed by vortex. Each standard was
centrifuged for ten minutes at 4000 rpm
Standard curves were generated for both the manual and automated
preparation methods for Compounds A and B. The calibration curves for
Compounds A and B are shown in Figures 9 and 10, respectively. A duplicate set of
calibration standards was analyzed with every concentration. A weighted method
(l/x) was used to construct each calibration plot for the peak area ratio of ana1yte to
internal standard versus analyte concentration. The calibration curves did appear to
be linear. There were no standard curve points deleted from Figures 9 and 10.
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'l'l • Automated std curve (Compound A): "Linear" Regression ("1 / x" weighting): y = 0.00323 x + -0.00377 (r2 = 0.9993)
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Figure 9. Calibration curves of Compound A with both the manual and automated methods are included in this figure. The
manual standard points are hollow points and the automated standard points are solid points.
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Figure 10. Calibration curves of Compound B with both the manual and automated methods are included in this Figure. The
manual standards have solid points and the automated standards have hollow points.
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In Figures 9 and 10 the manual sample preparation curves was slightly higher
than the automated curves. The systematic error may have occurred from the manual
pipets having a tolerance +/- 3%. The volumes may have been slightly greater than
expected. The rat plasma used was heparinized. The student's t-Test was used to
compare the two standard curves to determine if the data were within the acceptable
limit of a 95% confidence leveL The case 3 comparison of means with Student t test
was used to calculate the t statistic.33 There were two key calculations used in this
experiment for each of the compounds. The first equation was to determine the Sd or
the standard deviation of the individual experiment as shown below:
. 2 1/2Sd =[~(dl-dm,Ll
n-l
di - differences of the concentrations from each method at each leveL
davg - the average difference between the methods throughout all data points.
n - is the number of pairs of data (eight in this experiment)
1/2
tcalculated = davg _*( n)
Sd
tcalculated- the experimentally determined value for the t-test.
Table 2 and Table 3 display the standard curve individual data points from
compounds A and B, respectively. The calculations are also included below the
tables.
In this laboratory, there are usually between two and sixteen compounds in one
study with multiple subjects. Figure 11 illustrates a flowchart of the sequence for
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analyzing compounds, samples, and standards to meet the required short turnaround
times.
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Flowchart of Standards and Unknown Samples
ICompound I~ Std. Stock1.00 mg/ml
/
Infuse 1-.
Compound
Develop
LC/M S/M S
Method
Working Solution
100,20,2 and 0.2 J.lg/ml
!
Standard Curve
Dilutions
~
IDose Solution I
!
Dose Solution
Dilutions
~IS
LC/M S/M S
Analysis
Unknown
Samples
~
Figure 11. Flowchart ofthe process for analyzing multiple compounds. Step one - Prepare a 1.00 mg/mL stock solution
for each compound and infuse/determine parameters on the LC/MS/MS. Step two- create the standard curve from the four
working solutions and dilute the dose solutions. Add Internal Standard (IS) to the standard curve samples, diluted dose
solutions, and the unknown samples.
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Compound A Automated Compound A Manual
nominal cone. rep #1 rep #2 mean nominal cone. rep #1 rep #2 mean difference
10 10.1 11.6 10.9 10 12.2 10.6 11.4 0.5
25 25.0 26.1 25.5 25 30.3 30.7 30.5 5.0
50 47.3 49.4 48.4 50 62.4 57.3 59.9 11.5
100 96.5 94.7 95.6 100 118.5 96.4 107.5 11.9
250 264.9 238.9 251.9 250 292.6 263.7 278.2 26.3
500 507.5 468.1 487.8 500 555.3 558.6 557.0 69.2
1000 966.6 969.0 967.8 1000 1132.6 1102.0 1117.3 149.5
2500 2490.6 2603.7 2547.2 2500 2745.1 2614.5 2679.8 132.7
average d = 50.8
(0_0)2
2525.3
2100.6
1544.7
1517.3
602.8
336.6
9741.2
6699.0
3581.1
(0-0)
-50.3
-45.8
-39.3
-39.0
-24.6
18.3
98.7
81.8
SUM= Sd = 59.8
tc.lculaled = 2.246
Table 2. Comparison of the manual vs. automated calibration curve preparation using the student's t-test determination of Compound
A. At seven degrees of freedom for 95% confidence level the tcalculated and ttable were determined to be 2.246 and 2.365, respectively.
In this case, the tcalculated< ttable, thus the data are within the 95% confidence level. On the other hand, if tcalculated > ttable then the two
data sets would have been considered different from one another with 95% confidence.
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Compound B Automated Compound B Manual
nominal cone. rep #1 rep #2 mean nominal cone. rep #1 rep #2 mean difference
10 9.6 11.0 10.3 10 12.2 12.0 12.1 1.8
25 24.9 25.5 25.2 25 33.3 34.9 34.1 8.9
50 49.1 53.3 51.2 50 69.9 61.9 65.9 14.7
100 95.0 96.7 95.9 100 125.6 119.1 122.4 26.5
250 258.9 250.5 254.7 250 301.0 261.1 281.1 26.4
500 498.5 457.5 478.0 500 532.2 540.0 536.1 58.1
1000 983.8 999.7 991.8 1000 1108.8 1115.1 1112.0 120.2
2500 2453.1 2603.0 2528.1 2500 2550.2 2527.3 2538.8 10.7
average d = 33.4
(D-ol
999.0
600.6
349.9
47.7
49.8
609.8
7533.2
515.6
1529.3
(0-0)
-31.6
-24.5
-18.7
-6.9
-7.1
24.7
86.8
-22.7
SUM= Sd = 39.1
tcalculaled = 2.260
Table 3. Comparison of the manual ys. automated calibration curve preparation using the student's t-test determination for Compound
B. At seven degrees of freedom for 95% confidence level the tcalculated and ttable were determined to be 2.260 and 2.365, respectively.
In this case, the tcalculated < ttable, thus the data are within the 95% confidence level.
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Figure 12 displays a typical chromatogram at the LLQ (Lowest Limit of
Quantification) for compounds A and B. The LLQ and HLQ (Highest Limit of·
Quanification) for the experiment were 10 ng/mL and 2500 ng/mL, respectively based on
50 uL of rat plasma. Both compounds A and B had retention times of 0.63 minutes and
the internal standard has a retention time of 0.66. The solvent front eluted between 0.38
and 0.50 minutes for all compounds. The solvent front is the mate!ial from the vial that
is not retained on the column and is seen in the figure as the baseline of each
chromatogram. If the analytes were to elute at this particular time their signals would be
reduced dramatically.
Signal to Noise Ratios (SIN) for the LLQ of compounds A and B were
approximately lOll. Compounds A and B peaks had 4200 and 9000 counts, respectively.
The carryover for compounds A and B for this experiment were determined to be 0.08 %
and 0.13 %, respectively. Determination of the carryover was performed by analyzing a
2500 ng/mL (HLQ) and immediately injecting a blank sample with internal standard
added. The calculation of the internal ratio of analyte to internal standard will be
determined for both the HLQ and the blank. The internal ratio of the blank divided by
the internal ratio of the HLQ multiplied by 100 will give the percentage of carryover.
2'
The sequence of the run was performed by first analyzing the replicates of
standards following by the unknowns, and then running the second set of standards.
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Figure 12. Chromatogram at the LLQ (10 ng/mL) of Compounds A and B in rat plasma. Compounds A, B, and IS are the top,
middle and bottom chromatograms, respectively.
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Results of the Three Day Validation
The standard curves were prepared in duplicate each day by utilizing the
multiprobe with the same preparation as in Table 1, however, only compound A was
used. The first working solution was prepared by adding 40 uL of the 1.00 mg/mL
Compound A to 360 uL of 50/50 acetonitrile/water. The 1.00 mg/mL solution of
compound A for the standard was from a separate weighing than the quality control
1.00 mg/mL stock solution. The quality control samples (QCs) were prepared each
day by the multiprobe at four levels (l0 ng/mL, 25 ng/mL, 1000 ng/mL, and 2500
ng/mL). Each level of the quality control samples was prepared in six replicates,
therefore, 24 QC samples were generated per run. Blank samples were also used to
confirm minimal contamination and carryover levels. -The preparation of the QC
samples is in Table 4.
QC preparation
concentration (ng/mL)
2500
1000
25
10
Working
Std used volume of solution fuLl rat plasma volume (uL)
100 15 585
20 30 570
2 7.5 592.5
0.2 30 570
Table 4. Quality Control sample preparation. After the final concentrations are
prepared, the multiprobe aliquoted 50 uL of each level into six replicates.
One hundred ~L of internal standard (IS) in acetonitrile was added to the
tubes containing 50 uL of plasma and vortex mixed. All quality controls samples,
standards, and blanks were centrifuged for 10 minutes at 4000 rpm. Each run
consisted of 24 QC samples, 16 standards and 2 blank plasma samples. One of the
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blanks contained the internal standard and the other was protein precipitated with lOO
% acetonitrile. The results of the standards for the three runs are in Table 5. The
three runs were combined and statistics including the average mean, standard
deviation for all replicates, average bias, average %CV, within run precision, and
between run precision were calculated. The above results were calculated in the
following manner:
Bias =Mean concentration X 100 - 100
Nominal concentration
Average Bias =Biasrunl +Biasrun2 + Biasrun3
Number of Runs
% CV = Standard deviation of replicates * 100
Mean measured concentration
Average within-run precision = CVrun I + CVrun2 +CVrun3
Number of runs
Between run precision = S.D. determined from the within-run means X 100
Average of within-runs means
The results of the QC samples analyzed are in Table 6. The statistical
information for this validation is in Table 7.
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Back-calculated calibration standards and curve parameters for the three day validation of
Compound A
Calibration standard nominal concentration (ng/mL)
10 25 50 100 250 500 1000 2500 Slope Intercept 2r
RUN 1 10.7 26.3 54.2 85.0 267.1 467.7 957.2 2584.1 0.0017 0.0027 0.99896
11.0 26.6 48.0 88.5 254.0 454.8 996.0 2538.7
RUN 2 9.8 35.2 43.5 89.0 267.2 479.0 970.9 2556.0 . 0.0017 0.002 0.99808
10.3 32.3 40.6 85.0 228.9 478.5 921.5 2622.3
RUN 3 10.7 22.4 45.4 82.9 244.7 464.1 928.4 2576 0.0013 -0.0013 0.99806
12.5 28.6 50.5 93.5 282.1 505.6 913.7 2609
Mean 10.8 28.6 47.0 87.3 257.3 474.9 947.9 2581.0 0.0016 0.0011 0.99837
Std.Dev. 0.9 4.6 4.9 3.8 18.9 17.6 32.2 31.4
CVO/O 8.2 16.1 10,4 4,4 7.3 3.7 3,4 1.2
%of 108.4 114.3 94.1 87.3 102.9 95 94.8 103.2
Nominal
# of reps. 6 6 6 6 6 6 6 6
Table 5. Back calculated standards for all runs of the three day validation. Each level for each run had two replicates of
standards.
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c
Nominal Cone. (ng/mL)
10 25 1000· 2500
RUN 1 9.3 20.8 1022.5 2658.4
8.9 25.8 1091.9 2931.3
8.6 22.7 985.3 2849
9.1 25.7 959.7 2736.6
8.6 24.3 929 2617.5
8.3 22 889.5 2620.7
Mean 8.8 23.5 979.6 2735.6
S.D. 0.4 2.1 71.5 129.8
CV% 4.2 8.7 7.3 4.7
Bias % -12 -5.8 -2 9.4
Total number of rep. per run 6 6 6 6
RUN 2 7.9 24.9 1052.9 2837.6
9.7 23.8 1115.7 2537.5
10.6 24.2 1012.3 2748.1
9.4 24.9 999.3 2849
9.3 27.9 1114.9 2530.4
8.5 22.3 953.6 2599.7
Mean 9.2 24.7 1041.5 2683.7
S.D. 0.9 1.8 65.4 146.4
CV% 10.1 7.4 6.3 5.5
Bias % -7.8 -1.3 4.1 7.3
Total number of rep. per run 6 6 6 6
RUN 3 8.7 22.9 862.5 2364.5
11.3 27.3 832.4 2845.9
10.9 26.8 1018.0 2679.3
10.7 26.2 1031.6 2566.8
11.6 25.0 1015.2 2655.7
12.9 25.8 1027.3 2633.0
Mean 11.0 25.7 964.5 2624.2
S.D. 1.4 1.6 91.3 157.5
CV% 12.6 6.1 9.5 6.0
Bias % 10.2 2.8 -3.6 5.0
Total number of rep. per run 6 6 6 6
Table 6. Results and statistics of quality control samples in rat plasma in the three runs
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Nominal Cone. Nominal Cone. Nominal Cone. Nominal Cone.
(ng/mL) (ng/mL) (ng/mL) (ng/mL)
10 25 1000 2500
Mean of all quality
control samples 9.7 24.6 995.2 2681.2
S.D.
1.4 1.9 79.9 144.0
CV%
14.0 7.9 8.0 5.4
Average Bias %
-3.2 -1.5 -0.5 7.2
Total # reps
18.0 18.0 18.0 118.0
Average Within
Run Precision % 10.2 7.4 7.7 5.4
Between Run
Precision (%) 11.4 3.1 2.6 -1.0
Table 7. Overall results from the three runs of the quality control samples of
CompoundA.
Conclusions
The manual versus automated methods were analyzed from 10.0 ng/mL
to 2500 ng/mL for compounds A and B. The t statistic from the student's t test
for compounds A and B were 2.246 and 2.260, respectively. The 95 %
confidence level (7 degrees of freedom) student's ttable was 2.365. Since the
experimental results were less than the reference value the two methods are said
to be acceptable for both compounds A and B. The student's t third case was
used because two different methods were used to make single measurements on
different samples.
For compounds A and B, the standard curves for the automated
technique were slightly lower than the manual method. This may have been due
to small droplets from the wash station, which may have added a small amount
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of solvent and caused a slight dilution to all levels of standards. No wash
station was used for the standards when they were prepared manually. Another
type of systematic error may have been encountered by the accuracy of the pipet
used by the analyst. Calibration of the pipet is accurate only at an error of +/-
3%. The repeatability of duplicate measurements of the standard curve appeared
to be slightly better for the automated method than for the manual curve derived
from manually prepared samples. A few factors that may have contributed to
the lower regression for the manual method are human error, the use of different
pipets, and evaporation of the working solutions.
One of the most important advantages to using robotics over
manual sample preparation is that the amount time to prepare standards and
samples is cut in half. The analyst has more time to perform other important
tasks in the laboratory.
The three run validation had an LLQ of 10 ng/mL and an HLQ
(highest limit of quantification) of 2500 ngimL. The three day validation for
compound A was performed using the multiprobe since it was shown that both
the manual and automated methods were not distinctly different. The % cv,
average % cv, bias, and average bias for all four levels of quality control
samples must be within 15% including within and between run precision in
order to meet the Good Laboratory Practices guidelines. For this study, all of
the levels of quality control samples did meet these criteria. There were no
standards or quality control samples removed from the entire three day
validation.
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A rapid, sensitive, and selective LC/MS/MS method ha's been developed
and successfully validated for the determination of compound A--in this
experiment. This technique may be used for many other programs or types of
new chemical entities since it is a general detection and quantification procedure
with high selectivity. The key points that must be met to use this technique is
the sensitivity for formation of a molecular ion by the compound of interest.
This automated method is applicable for the analysis of other small organic
molecules.
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